Related Experiment Video
Updated: Aug 25, 2025

07:42
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
Published on: November 26, 2015
13.5K
Single-cell RNA-sequencing technology demonstrates the heterogeneity between aged prostate peripheral and
Qiuxia Yan1,2, Miao Wang2, Haoran Xia2
1Peking University Fifth School of Clinical Medicine, Beijing, China.
Clinical and Translational Medicine
|October 17, 2022
Summary
Aged prostate zones show distinct cell types and functions. The transitional zone (TZ) has more stem-like cells and inflammation, while the peripheral zone (PZ) shows increased MYC/E2F activity, impacting prostate disease understanding.
Area of Science:
- Urology
- Cell Biology
- Genomics
Background:
- Cellular and functional heterogeneity in the aged prostate is crucial for understanding disease distribution.
- Distinct zones, the peripheral zone (PZ) and transitional zone (TZ), exhibit unique cellular characteristics.
Purpose of the Study:
- To identify and characterize cellular heterogeneity within aged human prostate peripheral zone (PZ) and transitional zone (TZ).
- To elucidate the functional differences and spatial distribution of cell types between the PZ and TZ.
Main Methods:
- Single-cell RNA-sequencing of aged human prostate PZ and TZ tissues.
- Validation of findings using immunofluorescence staining.
Main Results:
- Club/hillock epithelial cells in the TZ display high NOTCH signaling and stem-like properties, with lower androgen gene expression.
- A novel TFF3+ luminal subtype with elevated MYC/E2F activity was identified in the PZ.
- The TZ exhibits higher stem and inflammation pathway activity but lower androgen/lineage activity compared to the PZ.
- The TZ immune microenvironment is more complex, with increased NK and Treg cells, and fibroblasts show heightened activity in immunity and proliferation.
Conclusions:
- Significant heterogeneity exists between the aged prostate TZ and PZ, characterized by distinct cellular compositions and functional pathways.
- These findings provide insights into the spatial distribution of prostate diseases and potential targets for novel therapies.

